T(H)-17 cells in the circle of immunity and autoimmunity (Q36765453)

16 August 2017

1 reference

title

T(H)-17 cells in the circle of immunity and autoimmunity (English)

1 reference

16 August 2017

3

Vijay K Kuchroo

1 reference

16 August 2017

Estelle Bettelli

1

1 reference

PubMed ID

17375096

16 August 2017

Mohamed Oukka

series ordinal

2

1 reference

PubMed ID

17375096

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

4

1 reference

16 August 2017

345-350

1 reference

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

From vanilla to 28 flavors: multiple varieties of T regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Oral tolerance and TGF-beta-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

The roles for cytokines in the generation and maintenance of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-17 family and IL-17 receptors

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-17 family members and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Airway neutrophils and interleukin-17.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IL-12 and IL-23: master regulators of innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Cytokine regulation of T-cell function: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Interferons in multiple sclerosis. A review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

A novel transcription factor, T-bet, directs Th1 lineage commitment

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Inducing and expanding regulatory T cell populations by foreign antigen

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-345

7 January 2021

Identifiers

DOI

10.1038/NI0407-345

1 reference

16 August 2017

1 reference

PubMed ID

17375096